Qigenix Partners with Researchers

Stem cell specialist Widecells Group PLC (LON:WDC) has inked a letter of intent with a California-based medical device company that could be worth up to £100,000.

Qigenix has agreed to pay the sum in three stages so it can use Widecell’s Institute of Stem Cell Technology (ISCT) in Manchester to undertake some research.

READ ENTIRE ARTICLE